When human synovial fluid as such was subjected to radioimmunoassays of prostaglandin E2 (PGE2) and leukotriene C4 (LTC4), there was no linear increase in PGE2 and LTC4 as the amount of synovial fluid was raised. For removal of substances thus disturbing the assay we developed a method of immunoaffinity purification of PGE2 and LTC4. A monoclonal antibody against PGE2 or LTC4 was coupled to BrCN-activated Sepharose 4B. When synovial fluid mixed with radiolabelled PGE2 or LTC4 was applied to the column of immobilized antibody, the ligand was adsorbed to the column and eluted with a mixture of methanol/water in a recovery of about 80%. The purified material showed a linearity between the amount of the sample and the value of radioimmunoassay. The one-step method was applied to synovial fluid from patients with rheumatoid arthritis, osteoarthritis and other joint diseases.
DahlénSEBjörkJHedqvistPArforsKEHammarströmSLindgrenJALeukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA1981; 78: 3887–91.
2.
IkedaKTanakaKKatoriM. Potentiation of bradykinin-induced vascular permeability increase by prostaglandin E2 and arachidonic acid in rabbit skin. Prostaglandins1975; 10: 747–58.
3.
AtickOS. Leukotriene B4 and prostaglandin E2-like activity in synovial fluid in osteoarthritis. Prostaglandins Leukotrienes and Essential Fatty Acids1990; 39: 253–4.
4.
BrodieMJHensbyCNParkeAGordonD. Is prostacyclin the major pro-inflammatory prostanoid in joint fluid?Life Science1980; 27: 603–8.
5.
DaymondTJRowellFJ. Reduction of prostaglandin E2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic acid or indomethacin treatment. Drugs1988; 35: 4–8.
6.
HeaveyDJRichmondRTurnerNCKobza-BlackATaylorGWChappellCGMeasurement of leukotriene C4 and D4 in inflammatory fluids. In: PiperPJ ed. The Leukotrienes, Their Biological Significance. New York: Raven Press, 1986; 185–98.
7.
KoshiharaYIsonoTOdaHKarubeSHayashiY. Measurement of sulfidopeptide leukotrienes and their metabolism in human synovial fluid of patients with rheumatoid arthritis. Prostaglandins Leukotrienes and Essential Fatty Acids1988; 32: 113–19.
8.
KurowskiMDunkyAGeddawiM. Effects of pirazolac on arachidonic acid metabolism in the human synovial system. Curr Med Res Opin1987; 10: 494–501.
9.
SawazakiY. Leukotriene B4, leukotriene C4 and prostaglandin E2 in the serum, synovial fluid and synovium in patients with rheumatoid arthritis. Journal of Nippon Medical School (in Japanese) 1989; 56: 33–8.
10.
RobinsonHJJrGrandaJL. Prostaglandins in synovial inflammatory disease. Surgical Forum1974; 25: 476–7.
11.
TokunagaMOhuchiKYoshizawaSTsurufujiSRikimaruAWakamatsuE. Change of prostaglandin E level in joint fluids after treatment with flurbiprofen in patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis1981; 40: 462–5.
12.
TrangLEGranströmELövgrenO. Levels of prostaglandins F2α and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis. Scand J Rheumatology1977; 6: 151–4.
13.
SeppäläENissiläMIsomäkiHWuorelaHVapaataloH. Effects of non-steroidal anti-inflammatory drugs and prednisolone on synovial fluid white cells, prostaglandin E2, leukotriene B4 and cyclic AMP in patients with rheumatoid arthritis. Scand J Rheumatology1990; 19: 71–5.
14.
WarrenDBlackburnJrLouisWHLelandDLEskraJDCartyTJ. Inhibition of 5-lipoxygenase product formation and polymorphonuclear cell degranulation by tenidap sodium in patients with rheumatoid arthritis. Arthritis and Rheumatism1991; 34: 204–10.
15.
OtsukaTKanieRImaizumiTOtaHMaedaMNotoKProstaglandin E in pathological synovial fluid. The Central Journal of Orthopaedic and Traumatic Surgery (in Japanese) 1981; 24: 917–25.
16.
ShonoFYokotaKHorieKYamamotoSYamashitaKWatanabeKA heterologous enzyme immunoassay of prostaglandin E2 using a stable enzyme-labeled hapten mimic. Anal Biochem1988; 168: 284–91.
17.
HayashiYShonoFYamamotoSTakasakiWNakagawaAWatanabeKImmunoaffinity purification of 11-dehydrothromboxane B2 from human urine and plasma for quantitative analysis by radioimmunoassay. Anal Biochem1990; 187: 151–9.
SnedecorGWCochranWG. Statistical Methods, 6th edn.Ames: The Iowa State University Press, 1967; 259–62.
20.
TaguchiG. Introduction to Quality Engineering. Asai Productivity Organization, Tokyo: 1986.
21.
ArnettFCEdworthySMBlochDAMcShaneDJFriesJFCooperNSThe American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum1988; 31: 315–24.
22.
SteinbrockerOTraegerCHBattermanRC. Therapeutic criteria in rheuatmoid arthritis. J Amer Med Assoc1949; 140: 659–62.
23.
ChiabrandoCBenigniAPiccinelliACarminatiCCozziERemuzziGAntibody-mediated extraction/negative-ion chemical ionization mass spectrometric measurement of thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine. Anal Biochem1987; 163: 255–62.
24.
HubbardHLEllerTDMaisDEHalushkaPVBakerRHBlairIAExtraction of thromboxane B2 from urine using an immobilized antibody column for subsequent analysis by gas chromatography-mass spectrometry. Prostaglandins1987; 33: 149–60.
25.
VrbanacJJEllerTDKnappDR. Quantitative analysis of 6-keto-prostaglandin F1α using immunoaffinity purification and gas chromatography-mass spectrometry. J Chromatogr1988; 425: 1–9.
26.
KrauseWJakobsUSchulzePENieuweboerBHümpelM. Development of antibody-mediated extraction followed by GC/MS (antibody/GC/MS) and its application to iloprost determination in plasma. Prostaglandins Leukotrienes and Medicine1985; 17: 167–82.
27.
NakagawaAMatsushitaYMuramatsuSTanishimaYHirotaTTakasakiWDevelopment of a selective clean-up method using immobilized antibody and its application to HPLC and GC/MS determination of a carbacyclin derivative, CS-570, in plasma. Biomed Chromatogr1987; 2: 203–8.
28.
RobinsonDRTashjianAHJrLevineL. Prostaglandin-stimulated bone resorption by rheumatoid synovia. J Clin Investigation1975; 56: 1181–8.
